255 related articles for article (PubMed ID: 30140263)
1. Smoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid Arthritis.
Wasén C; Erlandsson MC; Bossios A; Ekerljung L; Malmhäll C; Töyrä Silfverswärd S; Pullerits R; Lundbäck B; Bokarewa MI
Front Immunol; 2018; 9():1677. PubMed ID: 30140263
[TBL] [Abstract][Full Text] [Related]
2. Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study.
Wu X; Xu L; Cheng Q; Nie L; Zhang S; Du Y; Xue J
Respir Med; 2020 May; 166():105948. PubMed ID: 32250876
[TBL] [Abstract][Full Text] [Related]
3. Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.
Greisen SR; Rasmussen TK; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Hvid M; Deleuran B
Scand J Rheumatol; 2014; 43(2):101-8. PubMed ID: 24182347
[TBL] [Abstract][Full Text] [Related]
4. Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction.
Okuyama M; Mezawa H; Kawai T; Urashima M
Front Immunol; 2019; 10():86. PubMed ID: 30833943
[No Abstract] [Full Text] [Related]
5. Dysregulated Fc receptor function in active rheumatoid arthritis.
Magnusson SE; Wennerberg E; Matt P; Lindqvist U; Kleinau S
Immunol Lett; 2014 Nov; 162(1 Pt A):200-6. PubMed ID: 25194756
[TBL] [Abstract][Full Text] [Related]
6. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus].
Luo L; Shu M; Li S; Cai Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624
[TBL] [Abstract][Full Text] [Related]
7. The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.
Chang B; Huang T; Wei H; Shen L; Zhu D; He W; Chen Q; Zhang H; Li Y; Huang R; Li W; Wu P
Cancer Immunol Immunother; 2019 Mar; 68(3):353-363. PubMed ID: 30506460
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism on moxibustion for rheumatoid arthritis based on PD-1/PD-L1 signaling pathway].
Zhong YM; Wu F; Luo XC; Chen Y; Ren JG; Yang X; Ma WB; Zhou HY
Zhongguo Zhen Jiu; 2020 Sep; 40(9):976-82. PubMed ID: 32959594
[TBL] [Abstract][Full Text] [Related]
9. Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways.
Liu C; Jiang J; Gao L; Wang X; Hu X; Wu M; Wu J; Xu T; Shi Q; Zhang X
Arthritis Res Ther; 2015 Nov; 17():340. PubMed ID: 26608464
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity.
Hirahara S; Katsumata Y; Kawasumi H; Kawaguchi Y; Harigai M
Lupus; 2020 Jun; 29(7):686-696. PubMed ID: 32264742
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.
Cho I; Lee H; Yoon SE; Ryu KJ; Ko YH; Kim WS; Kim SJ
BMC Cancer; 2020 Feb; 20(1):120. PubMed ID: 32054467
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).
Martinsson K; Johansson A; Kastbom A; Skogh T
Clin Exp Immunol; 2017 Apr; 188(1):53-62. PubMed ID: 27859022
[TBL] [Abstract][Full Text] [Related]
14. Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer.
Zhang J; Zhang H; Luo Y
Med Sci Monit; 2019 Feb; 25():1275-1282. PubMed ID: 30771277
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.
Janssen KM; de Smit MJ; Brouwer E; de Kok FA; Kraan J; Altenburg J; Verheul MK; Trouw LA; van Winkelhoff AJ; Vissink A; Westra J
Arthritis Res Ther; 2015 Jul; 17(1):174. PubMed ID: 26155788
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity.
Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J
Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Tominaga T; Akiyoshi T; Yamamoto N; Taguchi S; Mori S; Nagasaki T; Fukunaga Y; Ueno M
PLoS One; 2019; 14(2):e0212978. PubMed ID: 30807610
[TBL] [Abstract][Full Text] [Related]
18. Influence of total glucosides of paeony on PD-1/PD-L1 expression in primary Sjögren's syndrome.
Chen Y; Wang Y; Xu L; Zhu W; Xu C; Xu M; Guo L; Hu W; Xu D; Jing R; Zhu Y; He J; Xu B
Int J Rheum Dis; 2019 Feb; 22(2):200-206. PubMed ID: 30338648
[TBL] [Abstract][Full Text] [Related]
19. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis.
Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J
BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367
[TBL] [Abstract][Full Text] [Related]
20. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
